Posts
avatar

Bro $ENLV just reported $1.23B in profit. Definitely not something you see on this space every day. The Nasdaq-listed biotech quietly turned itself into one of the most interesting plays in crypto by loading up on RAIN, the token powering a fully decentralized prediction markets and options protocol on Arbitrum. They’ve built a hybrid model: advancing their clinical-stage longevity/immunotherapy work (Allocetra for age-related inflammation) while running a serious digital asset treasury strategy centered on RAIN. Observing from the sidelines, this feels like a unique way to bridge TradFi and crypto conviction. Anyone else watching $ENLV? 👀

This content is for informational and educational purposes only. It may include third-party insights, sponsored content, or promotional material for which the creator may receive compensation. Nothing in this feed constitutes investment advice or a guarantee of returns. You are solely responsible for your own investment decisions. Always conduct your own research and exercise caution before trading. We do not guarantee the accuracy of third-party information and are not liable for any losses incurred. Past performance is not indicative of future results. Please refer to our Community Terms and Risk Disclosure Statement for details.

avatarPost your reply

Comment